HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 134 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $334,000 | +136.9% | 33,809 | +107.6% | 0.09% | +242.3% |
| Q2 2016 | $141,000 | -18.5% | 16,286 | -11.1% | 0.03% | +4.0% |
| Q1 2016 | $173,000 | -54.8% | 18,310 | -35.8% | 0.02% | -32.4% |
| Q3 2015 | $383,000 | -81.9% | 28,503 | -80.8% | 0.04% | -82.1% |
| Q1 2015 | $2,116,000 | +1013.7% | 148,179 | +610.2% | 0.21% | +1193.8% |
| Q3 2014 | $190,000 | -53.4% | 20,864 | -23.4% | 0.02% | -15.8% |
| Q4 2013 | $408,000 | -74.8% | 27,247 | -81.4% | 0.02% | -74.3% |
| Q3 2013 | $1,616,000 | +32.5% | 146,416 | -4.6% | 0.07% | +45.1% |
| Q2 2013 | $1,220,000 | – | 153,432 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |